An experimental new weight loss drug produced compelling data in an early stage clinical trial.
News & Analysis: ALTIMMUNE INC
ALT earnings call for the period ending March 31, 2021.
If you're thinking of investing in this spectacular coronavirus growth stock, now may be too late.
ALT earnings call for the period ending December 31, 2020.
The company's COVID-19 program is moving ahead.
This biotech just might have what it takes.
They're risky but could deliver huge returns in the new year.
It's down, but not out.
Investors are excited about an analyst's bullish opinion about the biotech stock.
A preprint is sending the biotech's shares higher today.